BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24673401)

  • 1. Camelid-derived heavy-chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris.
    Baghban R; Gargari SL; Rajabibazl M; Nazarian S; Bakherad H
    Biotechnol Appl Biochem; 2016; 63(2):200-5. PubMed ID: 24673401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH).
    Bakherad H; Mousavi Gargari SL; Rasooli I; Rajabibazl M; Mohammadi M; Ebrahimizadeh W; Safaee Ardakani L; Zare H
    Mol Biotechnol; 2013 Oct; 55(2):159-67. PubMed ID: 23666874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris.
    Rahbarizadeh F; Rasaee MJ; Forouzandeh M; Allameh AA
    Mol Immunol; 2006 Feb; 43(5):426-35. PubMed ID: 16337485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient production of nanobodies against urease activity ofHelicobacter pylori in Pichia pastoris.
    Pourasadi S; Mousavi Gargari SL; Rajabibazl M; Nazarian S
    Turk J Med Sci; 2017 Apr; 47(2):695-701. PubMed ID: 28425268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalently dimerized Camelidae antihuman TNFa single-domain antibodies expressed in yeast Pichia pastoris show superior neutralizing activity.
    Ji X; Lu W; Zhou H; Han D; Yang L; Wu H; Li J; Liu H; Zhang J; Cao P; Zhang S
    Appl Microbiol Biotechnol; 2013 Oct; 97(19):8547-58. PubMed ID: 23324801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Random mutagenesis of BoNT/E Hc nanobody to construct a secondary phage-display library.
    Shahi B; Mousavi Gargari SL; Rasooli I; Rajabi Bazl M; Hoseinpoor R
    J Appl Microbiol; 2014 Aug; 117(2):528-36. PubMed ID: 24766494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of recombinant botulism antigens: a review of expression systems.
    Moreira GM; Cunha CE; Salvarani FM; Gonçalves LA; Pires PS; Conceição FR; Lobato FC
    Anaerobe; 2014 Aug; 28():130-6. PubMed ID: 24930432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
    Moreira C; da Cunha CE; Moreira GM; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR
    Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, high level expression and immunogenicity of 1163-1256 residues of C-terminal heavy chain of C. botulinum neurotoxin type E.
    Mansour AA; Mousavi SL; Rasooli I; Nazarian S; Amani J; Farhadi N
    Biologicals; 2010 Mar; 38(2):260-4. PubMed ID: 19879159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fermentation, purification, and efficacy of a recombinant vaccine candidate against botulinum neurotoxin type F from Pichia pastoris.
    Byrne MP; Titball RW; Holley J; Smith LA
    Protein Expr Purif; 2000 Apr; 18(3):327-37. PubMed ID: 10733887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain.
    Zhou Y; Singh BR
    Protein Expr Purif; 2004 Mar; 34(1):8-16. PubMed ID: 14766296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of a neutralizing mouse-human chimeric antibody against botulinum neurotoxin serotype E.
    Mukamoto M; Maeda H; Kohda T; Nozaki C; Takahashi M; Kozaki S
    Jpn J Infect Dis; 2013; 66(1):46-50. PubMed ID: 23429085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High level expression, purification and immunogenicity analysis of a protective recombinant protein against botulinum neurotoxin type E.
    Valipour E; Moosavi ML; Amani J; Nazarian S
    World J Microbiol Biotechnol; 2014 Jun; 30(6):1861-7. PubMed ID: 24469548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of a recombinant heavy chain fragment C vaccine candidate against botulinum serotype C neurotoxin [rBoNTC(H(c))] expressed in Pichia pastoris.
    Dux MP; Huang J; Barent R; Inan M; Swanson ST; Sinha J; Ross JT; Smith LA; Smith TJ; Henderson I; Meagher MM
    Protein Expr Purif; 2011 Feb; 75(2):177-85. PubMed ID: 20933089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of thermostability in Camelus bactrianus (Bactrian camel) single-domain antibody specific for the mutant epidermal-growth-factor receptor expressed by Pichia.
    Omidfar K; Rasaee MJ; Kashanian S; Paknejad M; Bathaie Z
    Biotechnol Appl Biochem; 2007 Jan; 46(Pt 1):41-9. PubMed ID: 16848761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine.
    Yu YZ; Li N; Wang RL; Zhu HQ; Wang S; Yu WY; Sun ZW
    Clin Vaccine Immunol; 2008 Dec; 15(12):1819-23. PubMed ID: 18845829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.
    Derman Y; Selby K; Miethe S; Frenzel A; Liu Y; Rasetti-Escargueil C; Avril A; Pelat T; Urbain R; Fontayne A; Thullier P; Sesardic D; Lindström M; Hust M; Korkeala H
    Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and purification of the heavy-chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotrophic yeast Pichia pastoris.
    Potter KJ; Bevins MA; Vassilieva EV; Chiruvolu VR; Smith T; Smith LA; Meagher MM
    Protein Expr Purif; 1998 Aug; 13(3):357-65. PubMed ID: 9693060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function.
    Tremblay JM; Vazquez-Cintron E; Lam KH; Mukherjee J; Bedenice D; Ondeck CA; Conroy MT; Bodt SML; Winner BM; Webb RP; Ichtchenko K; Jin R; McNutt PM; Shoemaker CB
    Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32987745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins.
    Webb RP; Smith TJ; Wright PM; Montgomery VA; Meagher MM; Smith LA
    Vaccine; 2007 May; 25(21):4273-82. PubMed ID: 17395341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.